AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hims & Hers Health (HIMS) shares surged 2.60% today, marking the third consecutive day of gains, with a cumulative increase of 26.53% over the past three days. The stock price reached its highest level since March 2025, with an intraday gain of 5.59%.
Hims & Hers Health (HIMS) stock price movements following a new high: The stock's behavior over various periods after reaching a new high offers insights into potential future trends.Hims & Hers Health reported a strong financial performance for the first quarter of 2025, with revenue increasing by 111% year-over-year to $586 million, surpassing market expectations. The company also reported a GAAP profit of $0.20 per share, which was 66.4% above analysts’ consensus estimates, and an adjusted EBITDA of $91.06 million, beating estimates by 47.4%. The revenue guidance for the full year remains strong at $2.35 billion, with EBITDA guidance at $315 million, both above analyst estimates.
The company's customer base grew to 2.37 million, indicating a 48.6% year-on-year growth in customer base over the last two years. This suggests that the average customer is spending more on the company’s products and services each year. The growth in customer base is a positive indicator of the company's expanding market reach and increasing customer loyalty.
The appointment of a new chief operating officer, Nader Kabbani, a former Amazon executive, may have contributed positively to the stock movement. Leadership changes often influence investor sentiment, and the appointment of a seasoned executive from a well-known company like Amazon can instill confidence in the company's future prospects.

Knowing stock market today at a glance

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet